Schrodinger Operating Margin 2019-2025 | SDGR
Current and historical operating margin for Schrodinger (SDGR) over the last 10 years. The current operating profit margin for Schrodinger as of September 30, 2025 is -68.49%.
| Schrodinger Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.26B | $-0.17B | -66.54% |
| 2025-06-30 | $0.24B | $-0.19B | -81.09% |
| 2025-03-31 | $0.23B | $-0.19B | -83.91% |
| 2024-12-31 | $0.21B | $-0.21B | -100.97% |
| 2024-09-30 | $0.19B | $-0.22B | -112.95% |
| 2024-06-30 | $0.20B | $-0.21B | -102.49% |
| 2024-03-31 | $0.19B | $-0.21B | -113.23% |
| 2023-12-31 | $0.22B | $-0.18B | -82.03% |
| 2023-09-30 | $0.20B | $-0.18B | -88.50% |
| 2023-06-30 | $0.19B | $-0.17B | -86.08% |
| 2023-03-31 | $0.20B | $-0.15B | -75.63% |
| 2022-12-31 | $0.18B | $-0.15B | -81.22% |
| 2022-09-30 | $0.17B | $-0.14B | -82.94% |
| 2022-06-30 | $0.16B | $-0.13B | -79.75% |
| 2022-03-31 | $0.16B | $-0.12B | -75.48% |
| 2021-12-31 | $0.14B | $-0.11B | -81.16% |
| 2021-09-30 | $0.13B | $-0.11B | -84.80% |
| 2021-06-30 | $0.12B | $-0.09B | -71.07% |
| 2021-03-31 | $0.11B | $-0.07B | -64.04% |
| 2020-12-31 | $0.11B | $-0.06B | -56.48% |
| 2020-09-30 | $0.10B | $-0.05B | -51.49% |
| 2020-06-30 | $0.10B | $-0.05B | -50.53% |
| 2020-03-31 | $0.09B | $-0.05B | -49.45% |
| 2019-12-31 | $0.09B | $-0.04B | -45.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.286B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.404B | 55.40 |
| Tempus AI (TEM) | United States | $11.811B | 0.00 |
| Doximity (DOCS) | United States | $8.862B | 36.49 |
| Hims & Hers Health (HIMS) | United States | $8.100B | 65.89 |
| IRhythm Technologies (IRTC) | United States | $5.397B | 0.00 |
| Hinge Health (HNGE) | United States | $3.215B | 0.00 |
| Privia Health (PRVA) | United States | $2.856B | 178.62 |
| Inspire Medical Systems (INSP) | United States | $2.466B | 40.80 |
| Heartflow (HTFL) | United States | $2.248B | 0.00 |
| 10x Genomics (TXG) | United States | $1.987B | 0.00 |
| Enovis (ENOV) | United States | $1.618B | 8.50 |
| Omnicell (OMCL) | United States | $1.534B | 31.37 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Phreesia (PHR) | United States | $1.234B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.214B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.891B | 0.00 |
| Claritev (CTEV) | United States | $0.630B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 106.00 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.465B | 0.00 |
| Evolent Health (EVH) | United States | $0.432B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.327B | 0.00 |
| TruBridge (TBRG) | United States | $0.308B | 14.15 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.274B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.248B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.158B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.132B | 7.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.103B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| Pulmonx (LUNG) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |